ReviewInternational journal of hematology2022
Role of JAK inhibitors in myeloproliferative neoplasms: current point of view and perspectives.
Giuseppe G Loscocco et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this papertrialcites it